Page 149 - Orange Book Cumulative Supplement 10 October 2012

A - 12
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - ATRIPLA
N021937 001 5663169 Sep 02, 2014 U-750
5663169 Sep 02, 2014 U-1170
5811423 Aug 07, 2012 U-750
5811423 Aug 07, 2012 U-1170
5922695 Jul 25, 2017 DS U-750
5922695 Jul 25, 2017 DS U-1170
5935946 Jul 25, 2017 DS DP U-750
5935946 Jul 25, 2017 DS DP U-1170
5977089 Jul 25, 2017 DS DP U-750
5977089 Jul 25, 2017 DS DP U-1170
6043230 Jul 25, 2017 U-750
6043230 Jul 25, 2017 U-1170
6642245 Nov 04, 2020 U-750
6642245 Nov 04, 2020 U-1170
ELTROMBOPAG OLAMINE - PROMACTA
N022291 001 7160870 Nov 20, 2022 DS DP U-930

ELTROMBOPAG OLAMINE - PROMACTA
N022291 002 7160870 Nov 20, 2022 DS DP U-930

ELTROMBOPAG OLAMINE - PROMACTA
N022291 003 7160870 Nov 20, 2022 DS DP U-930
ELTROMBOPAG OLAMINE - PROMACTA
N022291 004 7160870 Nov 20, 2022 DS DP U-930
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE - COMPLERA
N202123 001 8080551 Apr 11, 2023 DS DP NCE May 20, 2016
8101629 Aug 09, 2022 DP

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - TRUVADA
N021752 001 5922695 Jul 25, 2017 DS U-1259
5922695 Jul 25, 2017 DS U-248
5922695 Jul 25, 2017 DS U-541
5922695 Jul 25, 2017 DS U-1170
5935946 Jul 25, 2017 DS DP U-541
5935946 Jul 25, 2017 DS DP U-1170
5935946 Jul 25, 2017 DS DP U-1259
5935946 Jul 25, 2017 DS DP U-248
5977089 Jul 25, 2017 DS DP U-1259
5977089 Jul 25, 2017 DS DP U-248
5977089 Jul 25, 2017 DS DP U-541
5977089 Jul 25, 2017 DS DP U-1170
6043230 Jul 25, 2017 DP U-541
6043230 Jul 25, 2017 DP U-1170
6043230 Jul 25, 2017 DP U-1259
6043230 Jul 25, 2017 DP U-248

ENTECAVIR - BARACLUDE
N021797 001 >A> NPP Oct 12, 2015
ENTECAVIR - BARACLUDE
N021797 002 >A> NPP Oct 12, 2015